BARD® Study of LIFESTREAM™ Balloon Expandable Covered Stent Treating Iliac Arterial Occlusive Disease



Status:Completed
Conditions:Peripheral Vascular Disease, Cardiology
Therapuetic Areas:Cardiology / Vascular Diseases
Healthy:No
Age Range:21 - Any
Updated:2/3/2019
Start Date:September 2014
End Date:December 2018

Use our guide to learn which trials are right for you!

A Prospective, Multi-Center, Non-Randomized, Single-Arm Study of the BARD® LIFESTREAM™ Balloon Expandable Vascular Covered Stent in the Treatment of Iliac Artery Occlusive Disease (BOLSTER)

Collect confirmatory evidence of the safety and effectiveness of the Balloon LIFESTREAM™
Stent Graft for the treatment of stenoses and occlusion in the iliac arteries.


CLINICAL INCLUSION CRITERIA:

- The subject provides written informed consent using an Informed Consent Form approved
by the Ethics Committee/ Institutional Review Board for the site.

- Subject agrees to comply with the protocol-mandated follow-up procedures and visits.

- Subject is a male or non-pregnant female ≥ 21 years old with an expected lifespan
sufficient to allow for completion of all study procedures.

- Subject has intermittent claudication (Rutherford Category 2-3) or ischemic rest pain
(Rutherford Category 4).

- Subject is able and willing to comply with any required medication regimen.

ANGIOGRAPHIC INCLUSION CRITERIA:

- Subject has evidence of single, bilateral, or multiple de novo and/or restenotic
(non-stented) lesion in the native common and/or external iliac artery that is ≥ 50%
stenosed (including total occlusions).

- The target lesion can be successfully crossed with a guide wire and pre-dilated with
an appropriately sized PTA balloon.

- The reference vessel diameter is between 4.5 mm -12.0 mm in diameter.

- The target lesion is ≤ 100 mm in combined length (per side).

- The subject has angiographic evidence of a patent (< 50% stenosis) profunda and/or
superficial femoral artery (SFA) in the target limb.

CLINICAL EXCLUSION CRITERIA:

- The subject is unable or unwilling to provide written informed consent or to conform
to the study protocol follow-up procedures and visits.

- The subject is or plans to become pregnant during the study.

- The subject is asymptomatic, has mild claudication or critical limb ischemia with
tissue loss described as Rutherford Category 0, 1, 5 or 6.

- The subject has a vascular graft previously implanted in the native iliac vessel.

- The subject suffered a hemorrhagic stroke or transient ischemic attack (TIA) within 3
months prior to the index procedure.

- The subject has a known uncorrectable bleeding diathesis or active coagulopathy.

- The subject has a serum creatinine ≥ 2.5 mg/dl or is on dialysis.

- The subject has a known allergy or sensitivity to stainless steel (i.e., Nickel),
ePTFE, or has intolerance to the antiplatelet, anticoagulant or thrombolytic
medications required per the protocol.

- The subject has a known allergy or sensitivity to contrast media, which cannot be
adequately pre-medicated.

- The subject had a prior vascular intervention within 30 days before or planned for
within 30 days after the index procedure.

- The subject has another medical condition, which may cause him/her to be non-compliant
with the protocol, confound the data interpretation, or is associated with a life
expectancy insufficient to allow for the completion of study procedures and follow-up.

- The subject is currently participating in an investigational drug, biologic, or
another device study.

ANGIOGRAPHIC EXCLUSION CRITERIA:

- The subject has extensive peripheral vascular disease, which in the opinion of the
Investigator, would preclude safe insertion of an introducer sheath. The ipsilateral
common femoral artery should be patent (< 50% stenosis).

- The target lesion requires treatment other than angioplasty to facilitate subject
device delivery.

- The subject has severe calcification of the target lesion, preventing inflation of PTA
balloon.

- The target lesion has been previously treated with a stent (bare or covered).

- The subject has angiographic evidence of acute thrombus at the target lesion.

- The target lesion involves the origin of the internal iliac artery such that
successful treatment of the lesion would require the subject device to cross/occlude
the side branch.

- The target lesion located in the distal external iliac artery such that successful
treatment of the lesion would require the subject device to cross/occlude side
branches or be exposed to compressive forces associated with the close proximity to
the common femoral artery.

- The subject has an abdominal aortic aneurysm (AAA) contiguous to the iliac artery
target lesion.

- The subject has a pre-existing target iliac artery aneurysm or perforation or
dissection of the target iliac artery prior to the initiation of the treatment for
this study.
We found this trial at
15
sites
Little Rock, Arkansas 72211
?
mi
from
Little Rock, AR
Click here to add this to my saved trials
Jacksonville, Florida 32207
?
mi
from
Jacksonville, FL
Click here to add this to my saved trials
?
mi
from
Bad Krozingen,
Click here to add this to my saved trials
Gainesville, Florida 32605
?
mi
from
Gainesville, FL
Click here to add this to my saved trials
Galveston, Texas 77550
?
mi
from
Galveston, TX
Click here to add this to my saved trials
Gastonia, North Carolina 28054
?
mi
from
Gastonia, NC
Click here to add this to my saved trials
Kansas City, Missouri 64116
?
mi
from
Kansas City, MO
Click here to add this to my saved trials
?
mi
from
Lakeland, FL
Click here to add this to my saved trials
Miami, Florida 33140
?
mi
from
Miami, FL
Click here to add this to my saved trials
?
mi
from
Orange, CA
Click here to add this to my saved trials
Raleigh, North Carolina 27607
?
mi
from
Raleigh, NC
Click here to add this to my saved trials
Sacramento, California 95817
?
mi
from
Sacramento, CA
Click here to add this to my saved trials
Sayre, Pennsylvania 18840
?
mi
from
Sayre, PA
Click here to add this to my saved trials
Seattle, Washington 98104
?
mi
from
Seattle, WA
Click here to add this to my saved trials
Worcester, Massachusetts 01655
?
mi
from
Worcester, MA
Click here to add this to my saved trials